What Is Microcurrent Therapy?

Transcranial electrotherapy stimulation (CES) is a completely different treatment method than traditional drug therapy and electroconvulsive therapy. It stimulates the brain with low-intensity trace currents, changes the abnormal brain waves in patients' brains, and promotes The brain secretes a series of neurotransmitters and hormones that are closely related to diseases such as anxiety, depression, and insomnia, in order to achieve treatment of these diseases.

Transcranial microcurrent stimulation

Transcranial electrotherapy stimulation (CES) is a completely different treatment method than traditional drug therapy and electroconvulsive therapy. It stimulates the brain with low-intensity trace currents, changes the abnormal brain waves in patients' brains, and promotes The brain secretes a series of neurotransmitters and neurotransmitters that are closely related to diseases such as anxiety, depression, and insomnia.

Compared with drug treatment, this treatment method does not have any side effects and has a stable effect. Therefore, it has been widely used in other countries in Europe and the United States, as a safe and effective treatment method for the treatment of anxiety, depression, insomnia and child-related diseases .

Although the CES treatment device has been used as a treatment device since 1981, the use of the CES treatment method has a long history. At least 2000 years ago,

The principle of CES treatment is essentially through the temporal direction

During the CES treatment process, users will experience a variety of pleasant feelings. They report that they feel "lighter", clearer, more creative. This relaxed and comfortable state is known in medicine as "Alpha status".

Most users report a significant reduction in anxiety levels during treatment. Other users report significant improvement in anxiety symptoms after two to three days of use, and some users need 9 to 10 times to see results.

So far, there have been 126 human studies on CES, 29 animal experiments, and more than 1,000 literature reports on CES treatments, four of which have been included in

In 2012, the FDA's evaluation of transcranial microcurrent stimulation devices for depression, anxiety, and chronic pain concluded that "there are currently few high-quality, reliable, and high-quality studies on transcranial microcurrent stimulation." For example, only 12.8% (5 of 39) were used for research

In the United States, transcranial microcurrent stimulation technology is regulated by the US Food and Drug Administration and is classified as a Class III medical device. Patients receiving transcranial microcurrent stimulation therapy must be prescribed or performed by a medical practitioner . Medical practitioners who prescribe transcranial microcurrent stimulation therapy need a permit based on the state regulations. Healthcare practitioners include doctors,

The exact mechanism of transcranial microcurrent stimulation is unknown. Some people have suggested that transcranial microcurrent stimulation can reduce those mental stresses that cause emotional disorders. Similar to the role of tonics, it balances the person's physiological system. This feature makes people not addicted to transcranial microcurrent stimulation, but instead forms a new habit. .

It has been proposed that the mechanism of transcranial microcurrent stimulation is that current pulses can enhance the ability of nerve cells to produce neurotransmitters such as serotonin, dopamine, dehydroepiandrosterone and endorphin, and stabilize the neurohormonal system.

The current increases the levels of serotonin, dopamine, and norepinephrine in the brain, and decreases the cortisol content. After transcranial microcurrent stimulation therapy, the patient is in a state of "alertness but relaxation", which is shown on the EEG, the alpha brain wave increases and the delta brain wave decreases.

During the transcranial microcurrent stimulation, the current mainly acts on the hypothalamus, and the electrodes are placed at the mastoid site, close to the human face. Computer simulations show that the cortex and subcortex will induce a current of approximately the same magnitude. This computer simulation has potential clinical significance.